China SXT Pharmaceuticals, Inc. Class A Ordinary Shares Share Price
NASDAQ: SXTCHealthcare
Live China SXT Pharmaceuticals, Inc. Class A Ordinary Shares Share Price Chart
O H L
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares Performance Overview
Days Range
▼
$2.35Low
$2.52High
Markets Today
| Previous Close | $2.44 |
|---|---|
| Open | $2.35 |
| Volume | 204,166 |
| Day's Range | $2.35 - $2.52 |
| 52W Range | $1.78 - $83,758.80 |
| Market Cap | $2.89 M |
Historical Performance
| 1M Returns | -52.53 |
|---|---|
| 3M Returns | -98.64 |
| 6M Returns | -98.20 |
| 1Y Returns | -99.99 |
| 5Y Returns | -100.00 |
| 10Y Returns | NA |
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares Fundamentals
| Market Cap | $2.89 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $1.14 M |
| ROE TTM | -0.27 |
| EPS TTM | $-98780.30 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.00 |
| EBITDA | $-6.07 M |
| Profit Margin | -545.24 |
| Market Cap | $2.89 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $1.14 M |
| ROE TTM | -0.27 |
| EPS TTM | $-98780.30 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.00 |
| EBITDA | $-6.07 M |
| Profit Margin | -545.24 |
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares Profit & Loss
Quarterly
| Total Revenue + |
| Gross Profit + |
| Operating Income |
| EBITDA |
| Interest Expense |
| Depreciation |
| Income Before Tax |
| Income Tax Expense |
| Net Income + |
| Net Profit Margin |
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares Financials Balance Sheet In USD
Quarterly
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $62.06 K | $162.47 K | $913.78 K | $39.67 M | $44.53 M | $64.13 M |
| Reserve & Surplus | -$9.42 M | -$14.73 M | -$21.81 M | -$25.74 M | -$29.09 M | -$34.42 M |
| Non-Current Liabilities | $6.29 K | $0 | $365.82 K | $294.67 K | $211.68 K | $697.83 K |
| Current Liabilities | $18.58 M | $17.12 M | $14.50 M | $8.90 M | $6.01 M | $4.35 M |
| Total Liabilities | $18.59 M | $17.12 M | $14.86 M | $9.20 M | $6.22 M | $5.05 M |
| Fixed Assets | $1.83 M | $1.63 M | $990.08 K | $347.95 K | $190.37 K | $123.43 K |
| Current Assets | $23.23 M | $22.45 M | $19.52 M | $14.23 M | $21.30 M | $34.51 M |
| Total Assets | $34.55 M | $33.55 M | $29.55 M | $23.13 M | $21.66 M | $34.75 M |
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares Cash Flow
Quarterly
| Net Income |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
| Change in Cash |
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares Return Calculator
The China SXT Pharmaceuticals, Inc. Class A Ordinary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$0
Invested Amount$10,000
Est. Returns$-10,000
About China SXT Pharmaceuticals, Inc. Class A Ordinary Shares
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
Popular Stocks
FAQs
What is the share price of China SXT Pharmaceuticals, Inc. Class A Ordinary Shares today?
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares (SXTC) share price as of September 18, 2026 is $2.35. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of China SXT Pharmaceuticals, Inc. Class A Ordinary Shares?
Yes, Indian Investors can invest in the China SXT Pharmaceuticals, Inc. Class A Ordinary Shares (SXTC) Share by opening an international trading account with Angel One.
How can I purchase China SXT Pharmaceuticals, Inc. Class A Ordinary Shares shares in India?
Purchasing China SXT Pharmaceuticals, Inc. Class A Ordinary Shares (SXTC) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying China SXT Pharmaceuticals, Inc. Class A Ordinary Shares (SXTC) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of China SXT Pharmaceuticals, Inc. Class A Ordinary Shares?
Yes, you can purchase fractional shares of China SXT Pharmaceuticals, Inc. Class A Ordinary Shares (SXTC) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of China SXT Pharmaceuticals, Inc. Class A Ordinary Shares?
The market capitalization of China SXT Pharmaceuticals, Inc. Class A Ordinary Shares on September 18, 2026, is $2.89 M.
In which sector China SXT Pharmaceuticals, Inc. Class A Ordinary Shares belongs?
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in China SXT Pharmaceuticals, Inc. Class A Ordinary Shares stocks?
In order to invest in China SXT Pharmaceuticals, Inc. Class A Ordinary Shares (SXTC) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
